Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt the 1mg dose, semaglutide has a half-life of roughly seven days, meaning it takes around five weeks for the medicine to clear your system entirely after your last injection. That extended half-life is by design: it keeps semaglutide active for a full week between doses, which is why Wegovy is injected once weekly. Understanding how long it lingers matters most when you are thinking about a missed dose, a planned break, switching treatments, or planning a pregnancy. These are clinical decisions, and a prescriber needs to weigh them with you — but the pharmacology itself is worth understanding. Wegovy is a prescription-only semaglutide injection for weight management in adults, and clinical assessment determines whether it is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide's half-life of around seven days is a fixed property of the molecule, not something that changes as the dose goes up or down. Whether you are at the 0.25mg starting point or the 2.4mg maintenance dose, each milligram you inject follows the same elimination curve. At the 1mg level specifically, roughly half of the active semaglutide in your body is cleared every seven days, and five clearance cycles (about five weeks) are generally required before it falls to negligible levels.
One misconception worth letting go quietly: some people assume that a lower dose clears faster because there is less of it. That is not how half-lives work. The proportion cleared per unit of time stays constant; the absolute amount diminishes logarithmically. So at 1mg, as at the 0.5mg stage, the timeline to full clearance is broadly the same five-week window.
The NHS medicines page for semaglutide confirms this pharmacokinetic profile, and it is also detailed in the NHS patient information for semaglutide. Clearance timelines can shift slightly with kidney function, body composition, and individual metabolism, which is why any decision based on this timeline should involve your prescriber rather than a calculation alone.
The pharmacokinetic timeline only becomes practically meaningful once you know what decision you are making. The answer looks different depending on the situation.
If you have missed a dose at the 1mg stage, the long half-life actually works in your favour: because semaglutide persists, a single missed weekly injection is unlikely to result in a sharp return of appetite the following day. The Patient Information Leaflet and your prescriber are the right sources for specific missed-dose guidance, none of this replaces that. For context on how the dose schedule works across the full titration, the Wegovy dosage plan page explains each step.
If you are thinking about stopping Wegovy, either briefly for surgery or permanently, the five-week clearance window is clinically significant. NHS England advises telling your anaesthetist and surgical team that you are taking a GLP-1 medicine before any procedure, because of the effects semaglutide has on gastric emptying. The medicine needs to have cleared sufficiently before certain general anaesthetics. Your surgical team will give you a specific stop date.
If you are planning a pregnancy or stopping contraception, the clearance window matters too: current guidance recommends ensuring the medicine has left your system before trying to conceive. That five-week estimate is the starting point, but your prescriber or GP should give you a personalised recommendation before you make any changes.
The standard Wegovy titration begins at 0.25mg, moves to 0.5mg, then to 1mg, before continuing upward through 1.7mg and toward the 2.4mg maintenance dose) or the newer 7.2mg option for those where higher doses are clinically appropriate. The full range of Wegovy doses is worth reading if you want the broader context of where 1mg fits.
At 1mg you are typically around 12 weeks into treatment. Steady state (the point at which the amount of semaglutide entering your body each week roughly equals the amount being cleared) is reached after approximately four to five doses at any given level. So by the time most people are injecting 1mg weekly, they have already passed through a period where semaglutide was building up, and a period where it held steady.
Stopping at this point means the clearance curve runs in reverse: the body works through those five half-lives, and most people notice the return of appetite or reduced satiety before the medicine has fully gone. That subjective experience moves faster than the pharmacokinetic reality. If you are considering what happens after the final dose more broadly, the clearance timeline after your last dose covers that in more depth.
The five-week clearance estimate is a pharmacokinetic guide, not a clinical instruction. Individual factors (kidney function, BMI, other medicines you take) can all influence how semaglutide is metabolised. And some situations genuinely need a clinical view rather than a general figure.
Any planned pause, dose change, or switch to a different treatment should be reviewed by a prescriber before you act on it. If you are seeing Wegovy treatment for the first time and wondering about costs alongside the pharmacology, the Wegovy cost page explains how UK private prescribing is priced. For anyone thinking about starting or continuing weight management treatment through a regulated online pharmacy, checking eligibility with our prescribers is the straightforward next step, consultations are free, and a named prescriber reviews every case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.